Mr. Bryan C. Hanson is Senior Vice President and Group President Surgical Solutions of Covidien Plc., since July 2011. Prior to that, from July 2006 to June 2011, Mr. Hanson served as President of Covidien?s Energybased Devices business. Mr. Hanson held several other positions of increasing responsibility in sales, marketing and general management with Covidien since October 1992.
The company has Return on Asset of 7.51 % which means that on every $100 spent on asset it made $7.51 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 17.21 % implying that it generated $17.21 on every 100 dollars invested.
The company has 5.08 B in debt with debt to equity (D/E) ratio of 0.46 which is OK given its current industry classification. Covidien plc has Current Ratio of 2.16 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
Covidien plc develops, manufactures, and sells healthcare solutions for use in clinical and home settings worldwide. Covidien plc [COV] is traded on New York Stock Exchange in USA. It is located in Dublin, and employs 43,400 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
NYSE Covidien plc
-0.06% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
Frankfurt
